Assessment of Pain: Sedation Safety in Gastrointestinal Endoscopy Trial

135 participants aged 18–65 were enrolled in a three-arm prospective study comparing ciprofol alone to ciprofol–etomidate mixtures for deep sedation. The dataset, authored by Boxuan Xu and last updated in June 2026, likely contains primary and secondary outcomes including adverse event incidence and sedation timing metrics. Trial registration details are provided for the study, which was registered on ChiCTR.gov.cn in November 2024.

Use Cases

• Compare adverse event rates between different sedation drug mixtures based on the described composite primary outcome.
• Analyze sedation induction and recovery times based on the secondary outcomes mentioned in the trial description.
• Model patient satisfaction and vital sign changes during gastrointestinal endoscopy procedures based on the described study measures.

Strengths

• Dataset is associated with a registered clinical trial (ChiCTR2400093109), providing a traceable research context.
• The study design is clearly described as a three-arm prospective trial with 135 participants and specific inclusion criteria.
• Primary and secondary outcomes are explicitly defined, including a composite measure of adverse events and several timing metrics.

Limitations

• The dataset is very small at 5.5 KB, indicating limited scope and likely a small number of records.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment for statistical modeling.

Provenance

Source

figshare, authored by Boxuan Xu.

Collection Method

Data collected from a three-arm randomized controlled clinical trial.

Time Range

Trial registered on Nov 28, 2024; specific data collection period is not stated.

Freshness

Last updated 2026-06-04 17:26:00; freshness should be verified.